ArticleAnnals of translational medicine2018

First-line osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer.

Byeong-Ho Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.